These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7025776)

  • 21. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
    Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
    Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis for the patients with chronic hepatitis B.
    Colić-Cvrlje V; Naumovski-Mihalić S; Prskalo M; Colić A; Cvjeticanin B; Sabarić B
    Coll Antropol; 2000 Jun; 24(1):211-6. PubMed ID: 10895548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.
    Hadziyannis SJ; Papatheodoridis GV
    Semin Liver Dis; 2006 May; 26(2):130-41. PubMed ID: 16673291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
    J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine.
    Kobayashi M; Suzuki F; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Yatsuji H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2007 Oct; 79(10):1472-7. PubMed ID: 17705186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current concepts in the diagnosis and management of hepatitis B surface antigen-positive chronic active hepatitis.
    Davis GL; Czaja AJ
    J Clin Gastroenterol; 1981 Dec; 3(4):381-8. PubMed ID: 6175681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiviral therapy of HBsAg positive chronic hepatitis: progress or erroneous development?].
    Hess G
    Med Klin (Munich); 1987 May; 82(11):419-20. PubMed ID: 3600545
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic hepatitis.
    Sherlock S
    Ann Acad Med Singap; 1980 Apr; 9(2):185-7. PubMed ID: 6158903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis of treated and untreated chronic-aggressive hepatitis].
    Knoblauch M; Ammann R; Clavadetscher P; Grob P; Schmid M
    Schweiz Med Wochenschr; 1976 Feb; 106(9):315-6. PubMed ID: 1257731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of chronic hepatitis (author's transl)].
    Siede W
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):57-69. PubMed ID: 378653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical therapeutics therapy for chronic hepatitis.
    Mwaungulu GS
    East Afr Med J; 1982 Nov; 59(11):705-10. PubMed ID: 6191941
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment problems in chronic hepatitis].
    Chernev K
    Vutr Boles; 1982; 21(1):6-12. PubMed ID: 6178223
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of chronic active hepatitis--newer aspects (author's transl)].
    Havemann K
    Immun Infekt; 1975 Aug; 3(4):199-206. PubMed ID: 1184101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.